# An Extension Study of PEAK Trial

> **NCT02763007** · PHASE4 · TERMINATED · sponsor: **Kun-Ho Yoon** · enrollment: 41 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** alogliptin+pioglitazone
- **DRUG:** alogliptin
- **DRUG:** pioglitazone

## Key facts

- **NCT ID:** NCT02763007
- **Lead sponsor:** Kun-Ho Yoon
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05-18
- **Primary completion:** 2018-12-19
- **Final completion:** 2019-02-28
- **Target enrollment:** 41 (ACTUAL)
- **Why stopped:** difficulty in recruiting patients
- **Last updated:** 2019-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02763007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02763007, "An Extension Study of PEAK Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02763007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*